Peripheral Vascular Interventions - Asia-Pacific Analysis and Market Forecasts Summary The peripheral vascular interventions market is a dynamic, billion-dollar market with solid growth potential through 2022. The rising prevalence of peripheral artery disease (PAD) combined with the increasing endovascular procedure rate will ensure that the market will continue to expand in the coming years. Recent technological advancements within this space, including drug-eluting stents and balloons, bioabsorbable stents (BAS), and polytetrafluoroethylene (PTFE)-covered stents have the potential to revolutionize the future of PAD treatment, as these devices provide improved solutions for complex pathologies. The technologies covered in this report include lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents. This report focuses on the peripheral vascular interventions market in the Asia-Pacific (APAC) (Australia, China, India, Japan, South Korea). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of different technologies. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. Highlights Key Questions Answered - What is the current and future peripheral vascular interventions market outlook in APAC? What trends are affecting the market? - Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment? - What are the unmet needs with the current generation of devices? How will emerging technologies fulfill these unmet needs? - What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for peripheral vascular interventions? - What are the challenges that have hindered widespread adoption of newer technologies? - With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the peripheral vascular interventions market? Scope - Overview of recent key industry events and analysis of their market impact. - Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2022. - Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market. - Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development. - Analysis of the current and future market competition in the peripheral vascular interventions market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Reasons To Buy - "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading vascular surgeons, interventional cardiologists, and interventional radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Table of Contents
1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 3 Market Access 3.1 Reimbursement Trends 3.1.1 Asia-Pacific 3.2 Mergers and Acquisitions/Key Partnerships 4 Unmet Needs and Market Opportunity Analysis 4.1 High Quality Data for Drug-eluting Balloons in Specific Indications 4.2 Minimizing Periprocedural Stroke Risk During Carotid Artery Interventions 4.2.1 Anti-thrombotic Coatings 4.2.2 Occlusion with Flow Reversal 4.2.3 Integrated Embolic Protection 4.3 Motorized Delivery Systems 4.4 Reducing Reintervention Rates 4.4.1 Controlled Drug Delivery Mechanisms 4.4.2 Improving Physician Training in Endovascular Techniques 5 Competitive Assessment 5.1 Market Share Analysis 5.1.1 Asia-Pacific 5.2 Key Companies and Product Profiles 5.2.1 Abbott Vascular 5.2.2 Biotronik 5.2.3 Boston Scientific 5.2.4 C.R. Bard 5.2.5 Cook Medical 5.2.6 Cordis (Cardinal Health) 5.2.7 Medtronic 5.2.8 Terumo 5.2.9 W.L. Gore 5.2.10 Other Players 5.3 Pipeline Products Assessment 6 Market Outlook 6.1 Procedure Trends 6.1.1 Treatment Paradigm 6.1.2 Lower Extremity Revascularization 6.1.3 Carotid Artery Stenting 6.1.4 Renal Artery Stenting 6.2 Global Market Drivers and Barriers 6.2.1 Driver: Rising Disease Prevalence 6.2.2 Driver: Rising Endovascular Procedure Rates 6.2.3 Driver: Improved Solutions for Superficial Femoral Artery Revascularization 6.2.4 Driver: Development of Low-profile Delivery Systems 6.2.5 Driver: Reduced Stent Fracture Rates with Second Generation Stents 6.2.6 Barrier: Impact of Current Reimbursement Schemes 6.2.7 Barrier: Lack of Rigorous Clinical Trials for Peripheral Bioabsorbable Stents 6.3 Market Outlooks by Geography 6.3.1 Asia-Pacific 7 Appendix 7.1 Bibliography 7.2 Abbreviations 7.3 Methodology 7.3.1 Overview 7.3.2 Coverage 7.3.3 Secondary Research 7.4 Forecasting Methodology 7.5 Physicians and Specialists Included in This Study 7.5.1 Key Opinion Leaders 7.6 Primary Research Summary 7.7 About the Authors 7.7.1 Analysts 7.7.2 Global Head of Medical Devices 7.7.3 About GlobalData 7.8 Disclaimer
List of Tables
Table 1: Key Mergers, Acquisitions, and Partnerships in Peripheral Vascular Interventions Market Table 2: Abbott Vascular - Company SWOT Analysis Table 3: Abbott Vascular - Marketed Products Assessment Table 4: Abbott Vascular - Clinical Trials to Watch Table 5: Biotronik - Company SWOT Analysis Table 6: Biotronik - Marketed Products Assessment Table 7: Biotronik - Clinical Trials to Watch Table 8: Boston Scientific - Company SWOT Analysis Table 9: Boston Scientific - Marketed Products Assessment Table 10: Boston Scientific - Clinical Trials to Watch Table 11: C.R. Bard - Company SWOT Analysis Table 12: C.R. Bard - Marketed Products Assessment Table 13: C.R. Bard - Clinical Trials to Watch Table 14: Cook Medical - Company SWOT Analysis Table 15: Cook Medical - Marketed Products Assessment Table 16: Cook Medical - Clinical Trials to Watch Table 17: Cordis (Cardinal Health) - Company SWOT Analysis Table 18: Cordis (Cardinal Health) - Marketed Products Assessment Table 19: Cordis (Cardinal Health) - Clinical Trials to Watch Table 20: Medtronic - Company SWOT Analysis Table 21: Medtronic - Marketed Products Assessment Table 22: Medtronic - Clinical Trials to Watch Table 23: Terumo - Company SWOT Analysis Table 24: Terumo - Marketed Products Assessment Table 25: Terumo - Clinical Trials to Watch Table 26: W.L. Gore - Company SWOT Analysis Table 27: W.L. Gore - Marketed Products Assessment Table 28: W.L. Gore - Clinical Trials to Watch Table 29: Other Players Assessment Table 30: Other Clinical Trials to Watch Table 31: Pipeline Products Assessment Table 32: Asia-Pacific Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022
List of Figures
Figure 1: APAC Market Shares for Lower Extremity Stents, by Company, 2015 Figure 2: APAC Market Shares for Standard PTA Balloons, by Company, 2015 Figure 3: APAC Market Shares for Standard PTA DEB, by Company, 2015 Figure 4: APAC Market Shares for Carotid Stents, by Company, 2015 Figure 5: Treatment Modalities - PAD Figure 6: Global Procedure Volume Forecast for Stenting in the Lower Extremity, by Artery, 2012-2022 Figure 7: Global Procedure Volume Forecast for Standard Balloon Angioplasty in the Lower Extremity, by Artery, 2012-2022 Figure 8: Global Procedure Volume Forecast for DEB Angioplasty in the Lower Extremity, by Artery, 2012-2022 Figure 9: Endovascular Treatment Patterns in the Iliac Arteries, by Region, 2015 Figure 10: Endovascular Treatment Patterns in the Femoropopliteal Arteries, by Region, 2015 Figure 11: Endovascular Treatment Patterns in the Infrapopliteal Arteries, by Region, 2015 Figure 12: Global Procedure Volume Forecast for Carotid Artery Stenting, 2012-2022 Figure 13: Global Procedure Volume Forecast for Renal Artery Stenting, 2012-2022 Figure 14: APAC Peripheral Vascular Interventions Market Forecast ($m), by Segment, 2012-2022 Figure 15: APAC Peripheral Vascular Interventions Market Comparison, by Segment, 2015 and 2022 Figure 16: Peripheral Vascular Survey Primary Research Participants, by Country
Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the markeRead More...
Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is antRead More...
Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.Read More...
Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive tRead More...
Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growiRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.